Jiangsu Hengrui Medicine
600276.SS
#477
Rank
A$67.13 B
Marketcap
$10.52
Share price
-1.63%
Change (1 day)
7.78%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total assets

Total assets on the balance sheet as of September 2024 : A$10.65 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total assets are A$10.65 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Jiangsu Hengrui Medicine - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2022-12-31A$9.02 B6.17%
2021-12-31A$8.49 B22.74%
2020-12-31A$6.92 B22.91%
2019-12-31A$5.63 B21.25%
2018-12-31A$4.64 B30.83%
2017-12-31A$3.55 B24.06%
2016-12-31A$2.86 B17.58%
2015-12-31A$2.43 B35.79%
2014-12-31A$1.79 B34.06%
2013-12-31A$1.33 B47.07%
2012-12-31A$0.90 B21.64%
2011-12-31A$0.74 B28.91%
2010-12-31A$0.57 B18.67%
2009-12-31A$0.48 B4.21%
2008-12-31A$0.46 B45.33%
2007-12-31A$0.32 B35.22%
2006-12-31A$0.23 B9.62%
2005-12-31A$0.21 B10.93%
2004-12-31A$0.19 B-16.88%
2003-12-31A$0.23 B-8.6%
2002-12-31A$0.25 B-2.5%
2001-12-31A$0.26 B